Asset Publisher

Hemophilia Drugs

To contribute to improved transparency around clinical management, Magellan Rx Hemophilia Management services will be used to perform utilization management and oversight of specialty pharmacy dispensing as part of this program.

For groups that have their pharmacy benefits carved in and participate in utilization management, Magellan Rx will perform the prior authorization (PA) drug reviews. The PA reviews will ensure that optimal dosing and products are being prescribed. 

Use the navigation on the left or the search function above to locate specific drug policy information.

Note: Coverage is subject to member’s specific benefits. Group-specific policies will supersede these policies when applicable. Please contact the customer service number on the back of the member’s ID card for group-specific policies and benefits.